CMS Grants New Technology Add-on Payment to the remedē® System for the Treatment of Central Sleep Apnea
Add-on Payment to Provide Additional Medicare Reimbursement for the remedē System
TREATING
CENTRAL SLEEP APNEA
Press Releases
Respicardia Announces First U.S. Commercial Case With The remedē ®System
Industry Veteran Peter Sommerness Joins as CEO to Lead U.S. Launch
Respicardia Closes $58.5 Million In Financing To Treat Central Sleep Apnea
Company announces strategic relationship with ZOLL Medical
Respicardia’s remedē ® System Receives FDA Approval
Breakthrough Treatment of Moderate to Severe Central Sleep Apnea in Adult Patients Now Available